Buspirone for Generalized Anxiety Disorder in Adults
Recommended Dosing and Titration
Start buspirone at 7.5 mg twice daily (15 mg/day total) and increase by 5 mg/day every 2-3 days as tolerated, targeting a therapeutic dose of 15-30 mg/day divided into 2-3 doses, with a maximum of 60 mg/day if needed. 1
Initial Dosing Strategy
- Begin with 7.5 mg twice daily or 5 mg three times daily to minimize initial side effects, particularly dizziness and nervousness 2, 3
- Increase gradually by 5 mg/day increments every 2-3 days until reaching the target therapeutic range 1
- Target dose is 15-30 mg/day divided into 2-3 daily doses, which has demonstrated efficacy in clinical trials 4, 2, 3
Dosing Flexibility
- Both twice-daily (BID) and three-times-daily (TID) regimens are equally effective - no significant differences in efficacy or safety were found between 15 mg BID versus 10 mg TID dosing 2, 5
- BID dosing may improve compliance without compromising efficacy or tolerability 5
- Maximum dose is 60 mg/day, though most patients respond to 30 mg/day or less 1, 6
Time to Therapeutic Effect
- Full anxiolytic effect requires 2-4 weeks of treatment - patients must be counseled about this delayed onset 4, 3
- This is a critical counseling point, as patients accustomed to benzodiazepines may expect immediate relief 7
Critical Safety Precautions
Contraindications and Severe Warnings
- Absolutely contraindicated with MAOIs - risk of serotonin syndrome 1
- Cannot be used in severe hepatic or renal impairment - buspirone levels increase significantly with lengthened half-life in these populations 1
- Discontinue 48 hours before urine catecholamine testing - buspirone causes false-positive results for pheochromocytoma 1
Major Drug Interactions Requiring Dose Adjustment
CYP3A4 inhibitors dramatically increase buspirone levels:
- Itraconazole increases buspirone AUC 19-fold - reduce buspirone to 2.5 mg daily 1
- Nefazodone increases buspirone AUC up to 50-fold - reduce buspirone to 2.5 mg daily 1
- Grapefruit juice increases buspirone AUC 9-fold - advise patients to avoid large amounts 1
- Ketoconazole and ritonavir similarly inhibit metabolism 1
CYP3A4 inducers dramatically decrease buspirone levels:
Monitoring and Precautions
- Monitor for warfarin interaction - one case report of prolonged prothrombin time when buspirone was added 1
- Take consistently with or without food - food increases bioavailability but slows absorption 4
- No routine laboratory monitoring required in patients with normal hepatic and renal function 3
Common Adverse Effects
- Most frequent side effects are dizziness, headache, nervousness, and nausea 4, 5, 6
- Palpitations occur more frequently with BID dosing (5% vs 1% with TID) 5
- Other common effects include somnolence and sweating 6
- Adverse effects are generally mild and dose-related - consider slowing titration if problematic 4, 6
Key Advantages Over Benzodiazepines
- No sedation, muscle relaxation, or psychomotor impairment 4
- No interaction with alcohol 4
- No physiologic dependence or withdrawal syndrome 4, 7
- Minimal abuse potential 4, 7
- Safe in overdose compared to benzodiazepines 7
Special Populations
Elderly Patients
- Use standard adult dosing - no age-related pharmacokinetic changes were observed 1
- Well-tolerated in elderly patients with similar safety profile to younger adults 1, 8
- Particularly advantageous in elderly due to lack of sedation and fall risk 8
Pregnancy and Lactation
- Pregnancy Category B - no fetal harm in animal studies, but use only if clearly needed as human data are limited 1
- Avoid in nursing mothers if clinically possible - excretion in human milk is unknown, though buspirone is excreted in rat milk 1
Pediatric Use
- Not effective in pediatric GAD - two placebo-controlled trials in 559 patients aged 6-17 years showed no significant benefit over placebo at doses of 15-60 mg/day 1